Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Quince Therapeutics Inc QNCX

Healthcare Biotechnology
Quince Therapeutics, Inc. is a late-stage biotechnology company. The Company is engaged in unlocking the patient’s own biology to deliver life-changing therapeutics to those living with rare diseases. The Company’s asset, EryDex, is being developed for the treatment of a rare neurodegenerative disease, Ataxia-Telangiectasia (A-T). EryDex utilizes a technology platform for autologous... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:QNCX)

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results

Business Wire April 1, 2024

Quince Therapeutics Launches Scientific Advisory Board

Business Wire February 22, 2024

Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors

Business Wire February 15, 2024

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

Business Wire February 7, 2024

Quince Therapeutics to Participate at Investor Events in January 2024

Business Wire January 4, 2024

Quince Therapeutics Completes Acquisition of EryDel S.p.A.

Business Wire October 23, 2023

U.S. FDA Partial Clinical Hold Lifted on IND for EryDel's Lead Phase 3 Asset EryDex for the Treatment of Ataxia-Telangiectasia

Business Wire September 28, 2023

Quince Therapeutics Appoints Dr. Charles S. Ryan as President

Business Wire September 6, 2023

Quince Therapeutics to Present at Sidoti Virtual Investor Conference on August 17, 2023

Business Wire August 10, 2023
View More News ››

Opinion & Analysis (NDAQ:QNCX)

Cortexyme Secures $125M Private Placement Capital to Advance Clinical Development

Streetwise Reports February 7, 2020
View More Opinion ››

Bullboard Posts (NDAQ:QNCX)

This place used to be cool

Now posts are always like three years old lol
Buzzworth - March 21, 2023

QNCX .... Woodshed a$$ whoopin

Lol $1.04 low of day !
Iseneschal - January 27, 2023

QNCX.... I'd say this is heading straight to the "Woodshed"

Happy Fryday Cheers !
Iseneschal - January 27, 2023

QNCX ...Vols are decreasing

Big coin toss  No position !!!
Iseneschal - January 27, 2023

QNCX ....N>L>O>D

make or break time !!! Happy Fryday !!!!!!!!!!
Iseneschal - January 27, 2023

QNCX ....U know the routine ; )

Now in PB mode....1 st support at $1.18 or if it breaks $1.38 on the upswing...I might be a buyer  Cheers !
Iseneschal - January 27, 2023
View more Bullboard ››

Kane Biotech Inc.

Kane Biotech Inc.

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and ...
View More »